Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 7/20 | 0.48 |
| ▸ | MC4R | P32245 | 2/20 | 0.35 |
| ▸ | MC5R | P33032 | 2/20 | 0.35 |
| ▸ | MC3R | P41968 | 2/20 | 0.35 |
| ▸ | MMP9 | P14780 | 2/20 | 0.35 |
| ▸ | FCER2 | P06734 | 2/20 | 0.35 |
| ▸ | MMP8 | P22894 | 1/20 | 0.34 |
| ▸ | TACR1 | P25103 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6318997 | 1.00 | GHSR (0.48) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6318989 | 1.00 | GHSR (0.48) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6316601 | 0.83 | GHSR (0.52) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6325178 | 0.83 | GHSR (0.52) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6325174 | 0.83 | GHSR (0.52) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6316607 | 0.83 | GHSR (0.52) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6318994 | 0.82 | GHSR (0.46) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL6325175 | 0.82 | GHSR (0.46) | GHSRMC4RMC5RMC3RMMP9 | |
| SCHEMBL7063312 | 0.78 | GHSR (0.39) | GHSRMC4RMC3RMMP9FCER2 | |
| SCHEMBL6317570 | 0.75 | FCER2 (0.47) | GHSRMC5RMMP9FCER2MMP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6555570-B2 | Growth hormone secretagogous with improved bioavailability | NOVO NORDISK A/S (DE) | 2003-04-29 | — | — | US | disclosed |